Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Ransohoff, T. Wei, K. Pavelko, J. Lee, P. Murray, Moses Rodriguez (2002)
Chemokine Expression in the Central Nervous System of Mice with a Viral Disease Resembling Multiple Sclerosis: Roles of CD4+ and CD8+ T Cells and Viral PersistenceJournal of Virology, 76
T. Sørensen, F. Sellebjerg, C. Jensen, R. Strieter, R. Ransohoff (2001)
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosisEuropean Journal of Neurology, 8
M. Manchester, D. Eto, M. Oldstone (1999)
Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic miceJournal of Neuroimmunology, 96
L. Izikson, R. Klein, I. Charo, H. Weiner, A. Luster (2000)
Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2)The Journal of Experimental Medicine, 192
Michael Liu, Benjamin Chen, P. Oertel, M. Buchmeier, D. Armstrong, T. Hamilton, T. Lane (2000)
Cutting Edge: The T Cell Chemoattractant IFN-Inducible Protein 10 Is Essential in Host Defense Against Viral-Induced Neurologic Disease1The Journal of Immunology, 165
W. Karpus, N. Lukacs, B. Mcrae, R. Strieter, S. Kunkel, Stephen Miller (1995)
An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.Journal of immunology, 155 10
J. Simpson, P. Rezaie, J. Newcombe, M. Cuzner, D. Male, M. Woodroofe (2000)
Expression of the β-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissueJournal of Neuroimmunology, 108
B. Fife, G. Huffnagle, W. Kuziel, W. Karpus (2000)
Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune EncephalomyelitisThe Journal of Experimental Medicine, 192
John Smith, M. Morris-Downes, F. Brennan, G. Wallace, S. Amor (2000)
A role for α4-integrin in the pathology following Semliki Forest virus infectionJournal of Neuroimmunology, 106
Michael Liu, H. Keirstead, T. Lane (2001)
Neutralization of the Chemokine CXCL10 Reduces Inflammatory Cell Invasion and Demyelination and Improves Neurological Function in a Viral Model of Multiple Sclerosis1The Journal of Immunology, 167
(2001)
CXCL10 (IFN-γ-Inducible Protein-10) Control of Encephalitogenic CD4 + T Cell Accumulation in the Central Nervous System During Experimental Autoimmune Encephalomyelitis
P. Murray, K. Krivacic, A. Chernosky, T. Wei, R. Ransohoff, M. Rodriguez (2000)
Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.Journal of neurovirology, 6 Suppl 1
V. Asensio, I. Campbell (1999)
Chemokines in the CNS: plurifunctional mediators in diverse statesTrends in Neurosciences, 22
R. Godiska, D. Chantry, G. Dietsch, P. Gray (1995)
Chemokine expression in murine experimental allergic encephalomyelitisJournal of Neuroimmunology, 58
D. Franciotta, G. Martino, E. Zardini, R. Furlan, R. Bergamaschi, L. Andreoni, V. Cosi (2001)
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapiesJournal of Neuroimmunology, 115
G. McFadden, P. Murphy (2000)
Host-related immunomodulators encoded by poxviruses and herpesviruses.Current opinion in microbiology, 3 4
Deren Huang, Yulong Han, M. Rani, A. Głąbiński, C. Trebst, T. Sørensen, M. Tani, Jintang Wang, Phil Chien, Sage O'Bryan, B. Bielecki, Zhijin Zhou, S. Majumder, R. Ransohoff (2000)
Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulationImmunological Reviews, 177
Patrick Voorn, J. Tekstra, R. Beelen, C. Tensen, P. Valk, C. GROOT (1999)
Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions.The American journal of pathology, 154 1
C. Gerard, B. Rollins (2001)
Chemokines and diseaseNature Immunology, 2
B. Rollins (2001)
Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease.The Journal of clinical investigation, 108 9
R. Ransohoff, K. Bacon (2000)
Chemokine receptor antagonism as a new therapy for multiple sclerosisExpert Opinion on Investigational Drugs, 9
D. Rossi, A. Zlotnik (2000)
The biology of chemokines and their receptors.Annual review of immunology, 18
Z. Qing, M. Sandor, Z. Radvany, Diane Sewell, A. Falus, D. Potthoff, W. Muller, Z. Fabry (2001)
Inhibition of Antigen‐Specific T Cell Trafficking into the Central Nervous System via Blocking PECAM1/CD31 MoleculeJNEN: Journal of Neuropathology & Experimental Neurology, 60
K. Balashov, J. Rottman, H. Weiner, W. Hancock (1999)
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.Proceedings of the National Academy of Sciences of the United States of America, 96 12
R. Weller (1998)
Pathology of Cerebrospinal Fluid and Interstitial Fluid of the CNS: Significance for Alzheimer Disease, Prion Disorders and Multiple SclerosisJournal of Neuropathology and Experimental Neurology, 57
P. Murphy, M. Baggiolini, I. Charo, C. Hébert, R. Horuk, K. Matsushima, L. Miller, J. Oppenheim, C. Power (2000)
International union of pharmacology. XXII. Nomenclature for chemokine receptors.Pharmacological reviews, 52 1
J. Hesselgesser, R. Horuk (1999)
Chemokine and chemokine receptor expression in the central nervous system.Journal of neurovirology, 5 1
T. Springer (1994)
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 76
K. Conant, A. Garzino-Demo, A. Nath, J. Mcarthur, W. Halliday, C. Power, R. Gallo, E. Major (1998)
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.Proceedings of the National Academy of Sciences of the United States of America, 95 6
C. Trebst, T. Sørensen, P. Kivisäkk, M. Cathcart, J. Hesselgesser, R. Horuk, F. Sellebjerg, H. Lassmann, R. Ransohoff (2001)
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.The American journal of pathology, 159 5
C. Trebst, R. Ransohoff (2001)
Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges.Archives of neurology, 58 12
A. Mantovani (1999)
The chemokine system: redundancy for robust outputs.Immunology today, 20 6
J. Hvas, J. Hvas, Catriona McLean, J. Justesen, G. Kannourakis, L. Steinman, J. Oksenberg, C. Bernard (1997)
Perivascular T Cells Express the Pro‐Inflammatory Chemokine RANTES mRNA in Multiple Sclerosis LesionsScandinavian Journal of Immunology, 46
Pia Kivisäkk, Corinna Trebst, Zhugong Liu, B. Tucky, T. Sørensen, R. Rudick, Matthias Mack, R. Ransohoff (2002)
T‐cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS traffickingClinical & Experimental Immunology, 129
P. Murphy (2001)
Viral exploitation and subversion of the immune system through chemokine mimicryNature Immunology, 2
T. Lane, V. Asensio, N. Yu, A. Paoletti, I. Campbell, M. Buchmeier (1998)
Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease.Journal of immunology, 160 2
Jianglin He, You-zhi Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, Xiaoyu Yang, W. Hofmann, W. Newman, C. Mackay, J. Sodroski, D. Gabuzda (1997)
CCR3 and CCR5 are co-receptors for HIV-1 infection of microgliaNature, 385
K. Bacon, J. Harrison (2000)
Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasisJournal of Neuroimmunology, 104
Dona Wu, S. Woodman, J. Weiss, C. Mcmanus, T. D’Aversa, J. Hesselgesser, E. Major, A. Nath, J. Berman (2000)
Mechanisms of leukocyte trafficking into the CNS.Journal of neurovirology, 6 Suppl 1
E. Sindern, Y. Niederkinkhaus, M. Henschel, L. Ossege, T. Patzold, J. Malin (2001)
Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis.Acta neurologica Scandinavica, 104 2
N. Woodroofe, A. Cross, K. Harkness, J. Simpson (1999)
The role of chemokines in the pathogenesis of multiple sclerosis.Advances in experimental medicine and biology, 468
A. Głąbiński, M. Tani, R. Strieter, V. Tuohy, R. Ransohoff (1997)
Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis.The American journal of pathology, 150 2
Kathy Hulkower, C. Brosnan, Dennis Aquino, Wendy Cammer, Sunita Kulshrestha, Michelle Guida, Davida Rapoport, Joan Berman (1993)
Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis.Journal of immunology, 150 6
W. Hickey, B. Hsu, H. Kimura (1991)
T‐lymphocyte entry into the central nervous systemJournal of Neuroscience Research, 28
W. Karpus, K. Kennedy (1997)
MIP‐1α and MCP‐1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphoctye differentiationJournal of Leukocyte Biology, 62
E. Sindern, Y. Niederkinkhaus, M. Henschel, L. Ossege, T. Patzold, J. Malin (2001)
Differential release of β‐chemokines in serum and CSF of patients with relapsing–remitting multiple sclerosisActa Neurologica Scandinavica, 104
A. Głąbiński, M. Tani, V. Tuohy, R. Tuthill, R. Ransohoff (1995)
Central Nervous System Chemokine mRNA Accumulation Follows Initial Leukocyte Entry at the Onset of Acute Murine Experimental Autoimmune EncephalomyelitisBrain, Behavior, and Immunity, 9
M. Tani, R. Ransohoff (1994)
Do Chemokines Mediate Inflammatory Cell Invasion of the Central Nervous System Parenchyma?Brain Pathology, 4
R. Ransohoff, T. Hamilton, M. Tani, M. Stoler, H. Shick, J. Major, M. Estes, Dawn Thomas, V. Tuohy (1993)
Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitisThe FASEB Journal, 7
E. Tran, W. Kuziel, T. Owens (2000)
Induction of experimental autoimmune encephalomyelitis in C57BL / 6 mice deficient in either the chemokine macrophage inflammatory protein‐1α or its CCR5 receptorEuropean Journal of Immunology, 30
J. Cyster (1999)
Chemokines and cell migration in secondary lymphoid organs.Science, 286 5447
P. Lowenstein (2002)
Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective.Trends in immunology, 23 1
W. Hickey (2001)
Basic principles of immunological surveillance of the normal central nervous systemGlia, 36
T. Sørensen, M. Tani, Jakob Jensen, V. Pierce, C. Lucchinetti, V. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. Strieter, J. Frederiksen, R. Ransohoff (1999)
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.The Journal of clinical investigation, 103 6
L. Gu, S. Tseng, Renée Horner, Carmen Tam, M. Loda, B. Rollins (2000)
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 404
T. Yednock, C. Cannon, L. Fritz, F. Sánchez‐Madrid, L. Steinman, N. Karin (1992)
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.Nature, 356 6364
Deren Huang, Jintang Wang, P. Kivisakk, B. Rollins, R. Ransohoff (2001)
Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune EncephalomyelitisThe Journal of Experimental Medicine, 193
M. Baggiolini (1998)
Chemokines and leukocyte trafficNature, 392
S. Rubin, T. Yednock, K. Carbone (1998)
In vivo treatment with anti-α 4 integrin suppresses clinical and pathological evidence of Borna disease virus infectionJournal of Neuroimmunology, 84
P. Kivisäkk, C. Trebst, D. Eckstein, A. Kerza-Kwiatecki, R. Ransohoff (2001)
Chemokine-based therapies for MS: how do we get there from here?Trends in immunology, 22 11
P. Loetscher, B. Moser, M. Baggiolini (2000)
Chemokines and their receptors in lymphocyte traffic and HIV infection.Advances in immunology, 74
L. Piccio, Barbara Rossi, E. Scarpini, C. Laudanna, C. Giagulli, A. Issekutz, D. Vestweber, E. Butcher, G. Constantin (2002)
Molecular Mechanisms Involved in Lymphocyte Recruitment in Inflamed Brain Microvessels: Critical Roles for P-Selectin Glycoprotein Ligand-1 and Heterotrimeric Gi-Linked Receptors1The Journal of Immunology, 168
W. Hickey, H. Kimura (1988)
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo.Science, 239 4837
H. Wekerle, Deming Sun, R. Oropeza-Wekerle, R. Meyermann (1987)
Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells.The Journal of experimental biology, 132
J. Rottman, A. Slavin, Robert Silva, H. Weiner, C. Gerard, W. Hancock (2000)
Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependentEuropean Journal of Immunology, 30
W. Catterall, K. Chandy, D. Clapham, G. Gutman, Franz Hofmann, A. Harmar, D. Abernethy, M. Spedding (2003)
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion ChannelsPharmacological Reviews, 55
A. Zlotnik, O. Yoshie (2000)
Chemokines: a new classification system and their role in immunity.Immunity, 12 2
C. Lucchinetti, R. Mandler, D. McGavern, W. Bruck, G. Gleich, R. Ransohoff, C. Trebst, B. Weinshenker, D. Wingerchuk, J. Parisi, H. Lassmann (2002)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.Brain : a journal of neurology, 125 Pt 7
C. Mcmanus, J. Berman, F. Brett, H. Staunton, M. Farrell, C. Brosnan (1998)
MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization studyJournal of Neuroimmunology, 86
W. Hickey (1991)
Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS InflammationBrain Pathology, 1
F. Lahrtz, L. Piali, K. Spanaus, J. Seebach, A. Fontana (1998)
Chemokines and chemotaxis of leukocytes in infectious meningitisJournal of Neuroimmunology, 85
W. Karpus, R. Ransohoff (1998)
Cutting Edge Commentary: Chemokine Regulation of Experimental Autoimmune Encephalomyelitis: Temporal and Spatial Expression Patterns Govern Disease PathogenesisThe Journal of Immunology
Chemokines and their receptors govern physiologic and pathologic leukocyte trafficking. The function of the chemokine system may be of particular interest for hematogenous leukocyte infiltration of the central nervous system (CNS) because of the distinct character of CNS inflammation and the exquisite specificity with which the chemokine system regulates cellular migration events. This review summarizes recent information about the expression and function of elements of the chemokine system in CNS inflammatory processes. Animal models of CNS demyelinating disease and the corresponding human disorder, multiple sclerosis are both considered
Journal of Infectious Diseases – Oxford University Press
Published: Dec 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.